Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Pneumothorax Treatment Devices Market Value Growth And Long-Term Outlook#_x000D_
The pneumothorax treatment devices market has experienced substantial growth recently. It is projected to expand from $3.98 billion in 2025 to $4.39 billion in 2026, at a compound annual growth rate (CAGR) of 10.3%. This historical growth can be attributed to several factors including an increase in traumatic chest injuries, a rise in road accident cases, improvements in hospital emergency infrastructure, the widespread adoption of chest tube procedures, and the expansion of critical care units._x000D_
_x000D_
The pneumothorax treatment devices market size is projected to experience substantial growth over the next few years. This market is anticipated to reach $6.43 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.0%. The expansion during the forecast period is primarily driven by factors such as the increasing availability of portable emergency devices, advancements in thoracic vent systems, a rise in ICU admissions, the demand for faster lung re-expansion, and the broadening of emergency medical services. Prominent trends expected in this period include rapid emergency lung decompression, the development of portable pneumothorax management devices, the integration of minimally invasive chest drainage, enhanced air leak control systems, and the introduction of simplified bedside treatment kits._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Pneumothorax Treatment Devices Market Demand Drivers: What’s Powering Industry Growth?#_x000D_
The rising incidence of respiratory ailments is projected to stimulate expansion in the pneumothorax treatment devices market. These conditions are medical issues impacting the lungs and airways, hindering respiration and oxygen uptake. Increases in respiratory diseases are often linked to factors such as air contamination, tobacco use, viral infections, and heightened allergen exposure. Pneumothorax treatment devices address collapsed lungs and re-establish normal breathing in individuals suffering from respiratory diseases. As an illustration, in September 2025, data from the Australian Bureau of Statistics, a government body in Australia, indicated that influenza-related fatalities climbed from 611 deaths in 2023 to 806 deaths in 2024, and further to 1,057 deaths by August 2025, marking a 73% growth from 2023 to the corresponding August 2025 timeframe. Furthermore, deaths associated with respiratory syncytial virus (RSV) saw an increase from 380 deaths in 2023 to 468 deaths in 2024, followed by 399 deaths in the year leading up to August 2025. Consequently, the growing prevalence of respiratory diseases is a key driver for the pneumothorax treatment devices market._x000D_
_x000D_
#Pneumothorax Treatment Devices Market Segment Analysis: What Are The Core Market Categories?#_x000D_
The pneumothorax treatment devices market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Ventilator Devices, Thoracic Vent Devices, Other Types_x000D_
2) By Application: Traumatic Pneumothorax, Spontaneous Pneumothorax, Other Applications_x000D_
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Ventilator Devices: Portable Ventilators, Non-Invasive Ventilators, Invasive Ventilators _x000D_
2) By Thoracic Vent Devices: Chest Drainage Systems, Heimlich Valves, One-Way Chest Valve Systems _x000D_
3) By Other Types: Needle Aspiration Devices, Pleural Catheters, Oxygen Therapy Devices _x000D_
_x000D_
#Pneumothorax Treatment Devices Market Innovation Trends: What Developments Are Reshaping The Industry?#_x000D_
Major companies operating in the pneumothorax treatment devices market are prioritizing the development of technologically advanced solutions, such as chest X-ray solutions, to sustain their position in the market. These chest X-ray solutions encompass imaging systems, equipment, and technologies crafted to capture detailed radiographic images of the chest, including the lungs, heart, ribs, and surrounding structures. For instance, in September 2023, Qure.ai, a US-based health tech company, announced it received 510(k) FDA clearance for its innovative chest X-ray solution, qXR-PTX-PE. This solution is specifically designed to assist in the rapid detection of pneumothorax (PTX) and pleural effusion (PE). The AI-enabled software enhances care pathways in intensive care units (ICUs) and emergency rooms (ERs) by providing timely notifications to healthcare professionals. The qXR-PTX-PE solution analyzes chest X-ray images for critical findings, significantly improving triage efficiency in emergency settings, where these conditions pose serious risks to patient health._x000D_
_x000D_
#Pneumothorax Treatment Devices Market Competitive Overview And Top Companies#_x000D_
Major companies operating in the pneumothorax treatment devices market are Cardinal Health Inc., Medtronic PLC, Siemens Healthineers AG, Medline Industries Inc., Fujifilm Holdings Corporation, Becton Dickinson and Company (BD), GE HealthCare Technologies Inc., Stryker Corporation, Boston Scientific Corporation, Draegerwerk AG & Co. KGaA, Cook Medical Inc., B. Braun Melsungen AG, Utah Medical Products Inc., Rocket Medical plc, Nobelpharma Co. Ltd., Sinapi Biomedical Inc., UreSil Inc., ATMOS MedizinTechnik GmbH & Co. KG, Betaglue Technologies S.p.A., Selio Medical Inc. _x000D_
_x000D_
#View The Full Pneumothorax Treatment Devices Market Report:#_x000D_
_x000D_
#Pneumothorax Treatment Devices Market Top Region: Where Does Most Revenue Come From?#_x000D_
North America was the largest region in the pneumothorax treatment devices market in 2025. The regions covered in the pneumothorax treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.